Medical technology company Conmed has completed the acquisition of US-based SurgiQuest, for around $265m.
The deal was first announced by both firms in November 2015. Conmed will include the acquired business in its advanced surgical business segment.
Based in Milford of Connecticut, SurgiQuest develops, manufactures, and markets advanced access technologies for minimally invasive surgery.
The firm manufactures patented AirSeal system, an integrated access management technology for use in laparoscopic and robotic procedures.
The integrated platform provides stable pneumoperitoneum, as well as continuously evacuates smoke and plume when energized medical devices such as electro-cautery, laser or ultrasound are used.
It also offers valve-free access to the abdominal cavity during both robotic and laparoscopic surgical procedures.
According to Conmed, AnchorPort, Low Impact Laparoscopy, AirSeal, and SurgiQuest are registered trademarks of SurgiQuest.
At the time of acquisition, Conmed president and CEO Curt Hart said: "Revitalizing the advanced surgical business is a key element of our general surgery strategy, and this transformative acquisition uniquely bolsters the progress we have made."
Based in Utica of New York, Conmed offers surgical devices and equipment for different specialties, comprising orthopedics, general surgery, gynecology, neurosurgery and gastroenterology.
Image: Conmed has acquired Connecticut-based SurgiQuest. Photo: courtesy of stockimages / FreeDigitalPhotos.net.